447 related articles for article (PubMed ID: 25901549)
1. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
[TBL] [Abstract][Full Text] [Related]
2. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
3. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
4. Stress Ulcer Prophylaxis in Critically Ill Children: A Multicenter Observational Study.
Duffett M; Chan A; Closs J; McGloin R; McKelvie G; Pong S; Seto W; Slaney H; Vaninetti G; Vanniyasingam T
Pediatr Crit Care Med; 2020 Feb; 21(2):e107-e113. PubMed ID: 31821206
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
[TBL] [Abstract][Full Text] [Related]
7. What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?
Patel AJ; Som R
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):356-60. PubMed ID: 23208652
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
9. Stress-related mucosal bleeding in critically ill oncology patients.
Bruno JJ; Canada TW; Wakefield CD; Nates JL
J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
MacLaren R; Campbell J
Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
13. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit.
Steinberg KP
Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662
[TBL] [Abstract][Full Text] [Related]
14. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
15. Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding.
Sochet AA; Son S; Ryan KS; Roddy M; Barrie E; Wilsey M; McKinley SD; Nakagawa TA
J Asthma; 2020 Aug; 57(8):858-865. PubMed ID: 31046509
[No Abstract] [Full Text] [Related]
16. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
Cook D; Guyatt G
N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
[No Abstract] [Full Text] [Related]
17. [Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors].
Tank S; Kerner T
Dtsch Med Wochenschr; 2014 Jun; 139(25-26):1338. PubMed ID: 24914510
[No Abstract] [Full Text] [Related]
18. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
[TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
Avendaño-Reyes JM; Jaramillo-Ramírez H
Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
